Wahed A, Dasgupta A
Dept of Pathology and Laboratory Medicine, University of Texas Houston Medical School, 6431 Fannin, MSB 2.292, Houston, TX 77030, USA.
Am J Clin Pathol. 2001 Sep;116(3):403-8. doi: 10.1309/3WXE-M27D-8HKG-VQTP.
Dan Shen, a traditional Chinese medicine used in the management of cardiovascular diseases, is now available without prescription in the United States from Chinese herbal stores. We demonstrated digoxin-like immunoreactivity of Dan Shen in vitro. Because Dan Shen is used to treat cardiovascular disease, we studied potential interference of Dan Shen with serum digoxin measurement. Addition of microliter quantities of Dan Shen extract to digoxin pools prepared from patients receiving digoxin resulted in falsely elevated serum digoxin concentrations (positive interference) as measured by the fluorescence polarization immunoassay for digoxin (Abbott Laboratories, Abbott Park, IL). More interestingly, serum digoxin concentrations were falsely lowered (negative interference) when measured by the microparticle enzyme immunoassay, also marketed by Abbott Laboratories. Taking advantage of poor protein binding of digoxin (25%) and high protein binding of digoxin-like immunoreactive components of Dan Shen, we further demonstrated that the positive and negative interference of Dan Shen in serum digoxin measurement can be eliminated by monitoring the free digoxin concentration.
丹参是一种用于治疗心血管疾病的传统中药,目前在美国的中草药商店无需处方即可买到。我们在体外证明了丹参具有地高辛样免疫反应性。由于丹参用于治疗心血管疾病,我们研究了丹参对血清地高辛测量的潜在干扰。向接受地高辛治疗患者的地高辛样本池中加入微量丹参提取物,通过地高辛荧光偏振免疫测定法(雅培实验室,伊利诺伊州雅培公园)测量,结果显示血清地高辛浓度出现错误升高(正干扰)。更有趣的是,当通过同样由雅培实验室销售的微粒酶免疫测定法测量时,血清地高辛浓度出现错误降低(负干扰)。利用地高辛蛋白结合率低(25%)以及丹参中地高辛样免疫反应性成分蛋白结合率高这一特点,我们进一步证明,通过监测游离地高辛浓度,可以消除丹参对血清地高辛测量的正干扰和负干扰。